| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | I198VBV98I |
| InChI Key | REOZWEGFPHTFEI-JKSUJKDBSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C19H26O2 |
| Molecular Weight | 286.42 |
| AlogP | 5.07 |
| Hydrogen Bond Acceptor | 2.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 4.0 |
| Polar Surface Area | 40.46 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 1.0 |
| Heavy Atoms | 21.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Enzyme
Hydrolase
|
- | 16600 | - | - | - | |
|
Ion channel
Voltage-gated ion channel
Transient receptor potential channel
|
420 | 900 | - | - | - | |
|
Membrane receptor
Family A G protein-coupled receptor
Small molecule receptor (family A GPCR)
Lipid-like ligand receptor (family A GPCR)
Cannabinoid receptor
|
- | - | - | 14710 | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Child Development Disorders, Pervasive | 2 | D002659 | ClinicalTrials |
| Prader-Willi Syndrome | 2 | D011218 | ClinicalTrials |
| Epilepsy | 1 | D004827 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL2387742 |
| DrugBank | DB14050 |
| FDA SRS | I198VBV98I |
| PubChem | 11601669 |
| SureChEMBL | SCHEMBL2759238 |
| ZINC | ZINC000005844413 |